Why the study?
Does blood urocortin2 (UCN2) level correlate with cardiac ejection fraction in patients with heart failure?
Observational (n=52)
Does blood urocortin2 (UCN2) level correlate with cardiac ejection fraction in patients with heart failure?
Answers are grounded in this paper and cite their sources.
Blood UCN2 levels negatively correlate with cardiac ejection fraction and may serve as a novel biomarker for assessing heart failure pathophysiology, independent of BNP.
Despite the efficacy of many therapies for heart failure, it remains a leading cause of morbidity and mortality worldwide, with many patients progressing to advanced stages of the condition. Since the standard treatment for heart failure includes small-molecule drugs targeting G protein-coupled receptors (GPCRs), GPCRs are still considered novel targets for the diagnosis and treatment of cardiovascular diseases. Corticotropin-releasing hormone receptor 2, a highly expressed GPCR in cardiomyocytes, and its ligand, urocortin2 (UCN2), have been reportedly associated with cardiovascular diseases; however, their clinical significance remains unclear. In this study, a UCN2 measurement assay was developed to measure blood UCN2 levels in patients with heart failure. The assay showed that blood UCN2 values indicated a negative relationship with cardiac ejection fraction in 52 patients with heart failure. Blood UCN2 levels were not correlated with brain natriuretic peptide, a standard marker of heart failure, and were higher in patients with cardiomyopathy than in those with heart failure, suggesting that measuring blood UCN2 levels may be a novel test for assessing the pathophysiology of heart failure.
No takes yet. Share an insight, caveat, or question.
Inukai et al. (2025) conducted an observational in Heart failure (n=52). Blood UCN2 levels was evaluated on Relationship with cardiac ejection fraction.
Synapse has enriched 10 related papers. Consider them for comparative context: